Indivior (LON:INDV) Stock Price Up 9.9% - Should You Buy?

Indivior PLC (LON:INDV - Get Free Report)'s stock price shot up 9.9% on Monday . The stock traded as high as GBX 1,090 ($14.88) and last traded at GBX 1,084 ($14.80). 496,685 shares were traded during trading, a decline of 39% from the average session volume of 808,406 shares. The stock had previously closed at GBX 986 ($13.46).

Indivior Trading Up 0.9%

The company has a debt-to-equity ratio of -170.06, a quick ratio of 1.52 and a current ratio of 0.83. The company has a market capitalization of £1.77 billion, a price-to-earnings ratio of -936.93, a P/E/G ratio of -5.57 and a beta of 0.19. The business's 50-day simple moving average is GBX 938.24 and its 200-day simple moving average is GBX 862.35.

Insider Buying and Selling at Indivior

In other Indivior news, insider Juliet Thompson acquired 1,925 shares of the business's stock in a transaction that occurred on Wednesday, June 11th. The shares were acquired at an average cost of GBX 1,388 ($18.95) per share, for a total transaction of £26,719 ($36,476.45). 3.44% of the stock is currently owned by company insiders.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.